arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ORAMED PHARMACEUTICALS INC.

ORMP

$4.29 ▼ -0.04 (-0.81%) at close

20 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bullish

auto_awesome

Analytical Summary

ORAMED PHARMACEUTICALS INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $177.6M

Dividend Yield 5.83%

Revenue Growth None

Op. Margin None

ROIC -6.4% ↗

FCF / Share $-0.22 ↘

Trailing P/E 2.8x

Price / Book 0.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

20-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.00M

↑ +49.3% —

Net Income Profit after all expenses

$64.05M

↑ +436.0% —

Operating Margin Operating profit as % of sales

-433.8%

↑ +1.1% —

FCF / Share Free cash flow per share

$-0.22

↓ -7.1% —

Long-Term Debt Long-term obligations

$9.66M

↓ -15.2% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↓

Returns

Cash Quality

Dividend History

Dividend / share · sourced from SEC filings

$0.25 Latest / share

FY 2014

FY 2015

FY 2016

FY 2017

FY 2018

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

$0.25

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2001 Apr 11, 2002 10-K ↗
Revenue Growth YoY (%)	—	—	-50.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-730%)	0.0% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	-0.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-103%)	0.3% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-97%)	10.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+30%)	-0.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-104%)	283.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3439%)	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	N/M	-59.0% Weak ↓ Weak Declining Year-over-year change in net income	-99.7% Weak ↓ Weak Declining Year-over-year change in net income	19.8% Good ↑ Good Improving Year-over-year change in net income	-12.8% Weak ↑ Weak Improving Year-over-year change in net income	-21.4% Weak ↑ Weak Improving Year-over-year change in net income	4.4% Caution ↑ Caution Improving Year-over-year change in net income	-51.6% Weak ↓ Weak Declining Year-over-year change in net income	-27.0% Weak ↑ Weak Improving Year-over-year change in net income	-34.6% Weak ↓ Weak Declining Year-over-year change in net income	-26.5% Weak ↓ Weak Declining Year-over-year change in net income	-114.2% Weak ↓ Weak Declining Year-over-year change in net income	47.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-7.9% Weak ↓ Weak Declining Year-over-year change in net income	0.3% Caution Caution Year-over-year change in net income	38.2% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	-7.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	21.1% Good Good Year-over-year change in free cash flow	64.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-9.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	—	-20.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	0.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	3.3% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	3.3% Caution Caution Compound annual revenue growth over 3 years	61.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-5.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	—	-11.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	1.9% Caution Caution Compound annual revenue growth over 5 years	33.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2001 Apr 11, 2002 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	-433.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2992%)	—	—	-438.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3024%)	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	15.0% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-20.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	-2.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-4.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-13.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	-424.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3640%)	—	—	-426.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3656%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-457.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	-462.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-479.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-237.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	-0.14x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.91x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2001 Apr 11, 2002 10-K ↗
Return on Invested Capital (%)	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-51.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-58.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-64.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-6.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-49.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-56.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	32.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+114%)	-13.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	3.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-78%)	-24.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-19.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-232%)	-35.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-333%)	-74.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-593%)	-40.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-373%)	-54.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-463%)	-41.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-379%)	-29.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-294%)	-27.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-283%)	-52.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-447%)	-88.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-690%)	-41.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-379%)	—	-100.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-770%)	-60.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-502%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2001 Apr 11, 2002 10-K ↗
Debt to Equity (x)	—	—	0.31x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-48%)	—	—	—	0.64x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+6%)	0.44x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-26%)	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	-7.74x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-45.95M	$-54.42M	$41.96M	$-40.46M	$-77.25M	$-19.30M	$9.03M	$8.84M	$-3.97M	$-3.91M	$-3.21M	$-1.76M	$-2.27M	$-4.43M	$-1.51M	—	—	—	—	—
Debt / EBITDA (x)	—	—	-3.28x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-0.85x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2001 Apr 11, 2002 10-K ↗
Revenue per Share (USD)	$0.05	—	$0.03	$0.07	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$1.53	$-0.48	$0.14	$-0.94	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.22	$-0.21	$-0.26	$-0.73	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Dividend per Share (USD)	$0.25	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.09	$3.66	$4.06	$3.84	$3.28	$1.39	$1.12	$1.79	$1.41	$1.99	$2.15	$2.06	$1.02	$0.57	$0.00	—	—	—	—	—
Tangible Book Value per Share (USD)	$5.09	$3.66	$4.06	$3.84	$3.28	$1.39	$1.12	$1.79	$1.41	$1.99	$2.15	$2.06	$1.02	$0.57	$0.00	—	—	—	—	—
Basic Weighted Avg Shares (shares)	41.40M	40.85M	40.32M	39.00M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2001 Apr 11, 2002 10-K ↗
Working Capital (USD)	$114.19M	$137.54M	$109.37M	$151.36M	$88.66M	$35.98M	$28.02M	$26.48M	$15.13M	$27.61M	$15.88M	$20.80M	$8.15M	$4.63M	$3.84M	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	$9.66M	$11.39M	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$199.74M	$146.26M	$163.82M	$151.81M	$115.77M	$32.88M	$19.39M	$31.11M	$19.24M	$26.19M	$24.83M	$20.79M	$8.13M	$3.78M	$3.72M	$830.27K	$2.75M	$4.59M	$513.13K	$53.70K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2001 Apr 11, 2002 10-K ↗
Sales/Revenue/Turnover (USD)	$2.00M	—	$1.34M	$2.70M	$2.70M	$2.71M	$2.70M	$2.45M	$2.46M	$641.00K	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$121.00K	$193.00K	$196.00K	$58.00K	$77.00K	$7.00K	$8.00K	$6.00K	$5.00K	$4.00K	$4.00K	$6.00K	$5.00K	$14.74K	$28.30K	—	—	—	—	—
Net Income, GAAP (USD)	$64.05M	$-19.06M	$5.53M	$-36.56M	$-22.99M	$-11.51M	$-14.36M	$-12.73M	$-10.48M	$-10.96M	$-7.23M	$-5.70M	$-4.23M	$-3.34M	$-1.56M	$-2.98M	$-2.76M	$-2.77M	$-4.48M	—
Operating Cash Flow (USD)	$-9.14M	$-8.41M	$-10.29M	$-27.92M	$-21.18M	$-12.44M	$-12.94M	$-14.66M	$-5.83M	$4.66M	$-4.95M	$-4.07M	$-3.40M	$-2.30M	$-1.71M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 79 quarters

ORAMED PHARMACEUTICALS INC.

Analytical Summary

20-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ORMP with peers